PAG
MDT icon

Paladin Advisory Group’s Medtronic MDT Stock Holding History

Paladin Advisory Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-132
Closed -$11.9K – 237
2024
Q3 		$11.9K Hold
132
– – 0.01% 197
2024
Q2 		$10.2K Hold
132
– – 0.01% 189
2024
Q1 		$11.5K Hold
132
– – 0.01% 189
2023
Q4 		$10.9K Sell
132
-38
-22% -$2.9K 0.01% 192
2023
Q3 		$13.3K Hold
170
– – 0.01% 205
2023
Q2 		$15K Hold
170
– – 0.01% 205
2023
Q1 		$13.7K Buy
+170
New +$13.9K 0.01% 205
2022
Q2 		– Sell
-631
Closed -$63.9K – 422
2022
Q1 		$71K Buy
+631
New +$66.7K 0.06% 147

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paladin Advisory Group's MDT Position: Q4 2024 in Review

Paladin Advisory Group sold out of Medtronic (MDT) in Q4 2024, closing a stake of 132 shares — an estimated $11.9K sold.

Paladin Advisory Group first reported a position in MDT in Q1 2022 and held it in 8 quarters. The position peaked at $71K in Q1 2022. 2,130 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Paladin Advisory Group reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Paladin Advisory Group sold 132 Medtronic shares in Q4 2024, an estimated $11.9K.
  • Paladin Advisory Group first reported a position in Medtronic in Q1 2022 and held it in 8 quarters.
  • Paladin Advisory Group's Medtronic position peaked at $71K in Q1 2022.
  • 2,130 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Paladin Advisory Group's 13F filing for Q4 2024, filed 23 Jan 2025.